JAHA:无症状性心肌梗死与心脏猝死长期风险之间的关系

2020-12-30 MedSci原创 MedSci原创

一般人群SMI与SCD风险增加有关

尽管无症状性心肌梗塞(SMI)在预后上很重要,但SMI患者发生猝死(SCD)的风险尚未明确。

近日,血管疾病领域权威杂志JAHA上发表了一篇研究文章,研究人员评估了2个基于社区的队列:社区动脉粥样硬化风险(ARIC)研究( n=13725)和心血管健康(CHS)研究(n=5207)。SMI被定义为基线时尚不存在但在随访期间新发的心肌梗死心电图证据。该研究的主要终点为医师确诊的SCD。

在ARIC研究中,25.4年的中位随访期间,发生了513例SMI,441例心肌梗塞(CMI)和527例SCD事件。SMI和CMI患者发生SCD的多变量风险比分别为5.20(95%CI为3.81-7.10)和3.80(95%CI为2.76-5.23)。在CHS中,中位随访时间为12.1年,发生了1070例SMI,632例CMI和526例SCD事件。SMI和CMI患者发生SCD的多变量风险比分别为1.70(95%CI为1.32-2.19)和4.08(95%CI为3.29-5.06)。SMI和CMI患者发生SCD的综合风险比分别为2.65(2.18–3.23)和3.99(3.34–4.77)。白人、男性和年龄较小与SMI相关的SCD风险更高。SMI患者SCD人群归因于比为11.1%,SMI与每1000人每年8.9例SCD的绝对风险增加相关。添加SMI可显著提高了对SCD和非SCD的预测效能。

由此可见,一般人群SMI与SCD风险增加有关

原始出处:

Yun‐Jiu Cheng.et al.Association Between Silent Myocardial Infarction and Long‐Term Risk of Sudden Cardiac Death.J AM HEART ASSOC.2020.https://www.ahajournals.org/doi/full/10.1161/JAHA.120.017044

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1268379, encodeId=15ae12683e9f5, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401352, encodeId=1fda140135266, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485140, encodeId=2bca1485140ca, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912104, encodeId=ccf1912104af, content=一般人群SMI与SCD风险增加有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Dec 30 09:53:16 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912089, encodeId=c50d912089fe, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34455379499, createdName=ms9000001535796802, createdTime=Wed Dec 30 08:29:45 CST 2020, time=2020-12-30, status=1, ipAttribution=)]
    2020-12-31 zhaohui6731
  2. [GetPortalCommentsPageByObjectIdResponse(id=1268379, encodeId=15ae12683e9f5, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401352, encodeId=1fda140135266, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485140, encodeId=2bca1485140ca, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912104, encodeId=ccf1912104af, content=一般人群SMI与SCD风险增加有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Dec 30 09:53:16 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912089, encodeId=c50d912089fe, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34455379499, createdName=ms9000001535796802, createdTime=Wed Dec 30 08:29:45 CST 2020, time=2020-12-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=1268379, encodeId=15ae12683e9f5, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401352, encodeId=1fda140135266, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485140, encodeId=2bca1485140ca, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912104, encodeId=ccf1912104af, content=一般人群SMI与SCD风险增加有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Dec 30 09:53:16 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912089, encodeId=c50d912089fe, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34455379499, createdName=ms9000001535796802, createdTime=Wed Dec 30 08:29:45 CST 2020, time=2020-12-30, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1268379, encodeId=15ae12683e9f5, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401352, encodeId=1fda140135266, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485140, encodeId=2bca1485140ca, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912104, encodeId=ccf1912104af, content=一般人群SMI与SCD风险增加有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Dec 30 09:53:16 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912089, encodeId=c50d912089fe, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34455379499, createdName=ms9000001535796802, createdTime=Wed Dec 30 08:29:45 CST 2020, time=2020-12-30, status=1, ipAttribution=)]
    2020-12-30 神盾医疗局局长Jack

    一般人群SMI与SCD风险增加有关

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1268379, encodeId=15ae12683e9f5, content=<a href='/topic/show?id=922f21183d' target=_blank style='color:#2F92EE;'>#AHA#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2118, encryptionId=922f21183d, topicName=AHA)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=bf3d82, createdName=zhaohui6731, createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1401352, encodeId=1fda140135266, content=<a href='/topic/show?id=80e89e0479a' target=_blank style='color:#2F92EE;'>#长期风险#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=46, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=97047, encryptionId=80e89e0479a, topicName=长期风险)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=4c37265, createdName=zhaojie88, createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1485140, encodeId=2bca1485140ca, content=<a href='/topic/show?id=4bbe5902ed2' target=_blank style='color:#2F92EE;'>#无症状#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=59027, encryptionId=4bbe5902ed2, topicName=无症状)], attachment=null, authenticateStatus=null, createdAvatar=Bioon/avatar/20180429/70baad2aa5a046c5aa2914d262de7d37.jpg, createdBy=bd077990475, createdName=12498da4m34(暂无昵称), createdTime=Thu Dec 31 23:18:57 CST 2020, time=2020-12-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912104, encodeId=ccf1912104af, content=一般人群SMI与SCD风险增加有关, beContent=null, objectType=article, channel=null, level=null, likeNumber=84, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20200529/3611e9bb629c4e5b81fbd8ce784b06cc/128487eae357460bb98f67d86230c218.jpg, createdBy=ab235268530, createdName=神盾医疗局局长Jack, createdTime=Wed Dec 30 09:53:16 CST 2020, time=2020-12-30, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=912089, encodeId=c50d912089fe, content=学习了!, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=34455379499, createdName=ms9000001535796802, createdTime=Wed Dec 30 08:29:45 CST 2020, time=2020-12-30, status=1, ipAttribution=)]
    2020-12-30 ms9000001535796802

    学习了!

    0

相关资讯

JAHA:急性心肌梗死患者体重指数与心脏猝死

由此可见,肥胖(BMI≥27.5kg/ m2)与心肌梗死患者的SCD风险相关,尽管在全因死亡率方面存在肥胖悖论。

JAHA:二尖瓣脱垂与心脏猝死的关系

由此可见,孤立性MVP和SCD主要影响年轻女性冗余的双叶脱垂,心脏骤停通常由于室性心律失常所致。为了更好地理解MVP和SCD之间的复杂关系,需要通过纵向随访对临床、电生理和心脏成像参数进行标准化报告。

JAHA:颈动脉内膜中层厚度与心脏猝死风险

在两个基于社区的队列中,C‐IMT与SCD风险相关。C‐IMT可用作SCD风险的标志物,并有可能启动早期治疗干预措施以降低风险。

Heart:肥厚型心肌病患者脑利钠肽前体N末端与心脏猝死

肥厚型心肌病(HCM)患者脑利钠肽前体N末端(NT-proBNP)水平升高与心力衰竭相关死亡相关,但HCM患者NT-proBNP水平与心脏猝死(SCD)之间的关系尚未明确。

Eur Heart J:心脏再同步治疗的心力衰竭患者心脏猝死风险的时间趋势

由此可见,随着时间的推移,CRT治疗的心力衰竭人群心脏猝死发生率逐渐降低。CRT-D与CRT-P接受者之间的差异明显缩小。

JACC:有心脏猝死家族史的儿童的心血管风险评估

青少年时期的心脏猝死可能增加一级亲属心血管疾病的发生风险,但是对一级亲属进行筛查的效果产出尚不清楚。本研究的目的旨在探究家族中存在心脏猝死的儿童的心血管风险预测因素。本研究纳入分析了419名因一级亲属有心脏猝死而就诊的儿童,其中27%的儿童被诊断为存在疾病或可能存在疾病。有39名(9.3%)儿童被诊断为遗传性心脏病,另外5.5%儿童诊断为非遗传性心脏病。临床诊断不确定的有52名,包括异常的电生理检